50
Participants
Start Date
May 19, 2016
Primary Completion Date
May 31, 2026
Study Completion Date
May 31, 2026
Enzalutamide
assessment
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Westchester, Harrison
Kings County Hopsital Center, Brooklyn
Coney Island Hospital, Brooklyn
Queens Hospital Center, Jamaica
Memorial Sloan Kettering Nassau, Uniondale
Memorial Sloan Kettering Commack, Commack
Lehigh Valley Health Network, Allentown
Hartford Healthcare Cancer Institute @ Hartford Hospital, Hartford
Memorial Sloan Kettering Basking Ridge, Basking Ridge
Memorial Sloan Kettering Monmouth, Middletown
Woodhull Hospital, Brooklyn
Collaborators (2)
Medivation, Inc.
INDUSTRY
Astellas Pharma Inc
INDUSTRY
Memorial Sloan Kettering Cancer Center
OTHER